Archived Webinars

Leveraging Public Opinion in Support of Science

Original air date: December 4, 2017

Featuring: Mary Woolley, president and CEO, Research!America; Christopher Volpe, Ph.D., executive director, ScienceCounts; and Navneet Matharu, Ph.D., postdoctoral fellow, University of California San Francisco

Public support of science can be instrumental in influencing congressional support of research funding. While public support for science is strong, few Americans understand our nation’s scientific enterprise. Speakers provide tips for effectively communicating about the importance of science, the patient experience, and recent discoveries that have potential policy implications to increase public support of federally-funded scientific research. 

Click here to view a recording of the webinar. 


Innovative Research and the Opioid Epidemic: Are We Closer to Finding Solutions?

Original air date: October 13, 2017

Featuring: Nora Volkow, M.D., Director, National Institute on Drug Abuse at the National Institutes of Health; Georges Benjamin, M.D., Executive Director, American Public Health Association; and Jeffrey Bratberg, Pharm.D., Clinical Professor, University of Rhode Island College of Pharmacy

As the opioid epidemic continues to intensify, innovative scientific solutions provide much needed hope to alleviate the suffering of the tens of thousands of Americans. Experts discuss the role of research, implications for public health and the role of pharmacists in addressing the crisis. 

To learn more: view the slides and watch a recording of the webinar. 


The Fogarty International Center: How Americans Benefit from Global Health Research

Original air date: May 25, 2017

Sponsored by: the Infectious Diseases Society of America, the American Society of Tropical Medicine and Hygiene, and Research!America

Featuring: Roger Glass, M.D., Ph.D., Director of The Fogarty International Center at NIH; Chris Beyrer, M.D., MPH, Johns Hopkins Bloomberg School of Public Health; Bob Bollinger, M.D., MPH, Johns Hopkins Bloomberg School of Public Health; and Christine Lubinski, Vice President for Global Health Infectious Diseases Society of America (IDSA)

“Diseases Know No Borders” – investment in prevention and infrastructure is vital to protecting future generations from outbreaks such as Ebola and Zika. Did you know that 80% of the funding for global health initiatives goes to scientists and institutions right here in the U.S.? The rest is invested in creating sustainable platforms for containing outbreaks before they reach the U.S.

To learn more: watch the webinar here.


The Microbiome Initiative: A Closer Look 

Original air date: September 16, 2016

Sponsored by: the American Society for Microbiology and Research!America

Featuring: Dr. Stefano Bertuzzi, Executive Director and CEO of the American Society for Microbiology

Microbiomes live on or in people, plants, soil, oceans, and the atmosphere. How do they affect human health? The National Microbiome Initiative (NMI) is a collaborative effort by federal agencies and private-sector stakeholders to support research, develop technology, and expand the microbiome workforce. Innovative breakthroughs in health, technology, environmental science, and biofuels are on the horizon.

To learn more: watch the webinar here.


Media Contacts

Suzanne Ffolkes
VP Communications

Anna Briseño
Senior Manager of Communications

Without continued support for health research, many of the most promising young scientists, their ideas and a myriad of potentially life-changing scientific breakthroughs will vanish into oblivion.
Paul Marinec, PhD; University of California San Francisco